Dermapharm
DMP.F
$71.49
Share price
0.00%
Change (1 day)
19.61%
Change (1 year)
Revenue for Dermapharm (DMP.F)
Revenue in 2024 (TTM): NZ$2.11 Billion
According to Dermapharm's latest financial reports the company's current revenue (TTM 
) is NZ$2.17 Billion. an increase over the revenue in the year 2023 that were of NZ$1.94 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dermapharm from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$2.25 B | 15.86% |
| 2023 | NZ$1.94 B | 14.64% |
| 2022 | NZ$1.69 B | 5.97% |
| 2021 | NZ$1.60 B | 25.6% |
| 2020 | NZ$1.27 B | 9.69% |
| 2019 | NZ$1.16 B | 15.93% |
| 2018 | NZ$1.00 B | 33.16% |
| 2017 | NZ$0.75 B |